These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8014346)

  • 21. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.
    Galvin JE; Powlishta KK; Wilkins K; McKeel DW; Xiong C; Grant E; Storandt M; Morris JC
    Arch Neurol; 2005 May; 62(5):758-65. PubMed ID: 15883263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairment and risk of stroke in the older population.
    Ferrucci L; Guralnik JM; Salive ME; Pahor M; Corti MC; Baroni A; Havlik RJ
    J Am Geriatr Soc; 1996 Mar; 44(3):237-41. PubMed ID: 8600190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of diagnosis on death certificates for underlying causes of death in a long-term autopsy-based population study in Hisayama, Japan; with special reference to cardiovascular diseases.
    Hasuo Y; Ueda K; Kiyohara Y; Wada J; Kawano H; Kato I; Yanai T; Fujii I; Omae T; Fujishima M
    J Clin Epidemiol; 1989; 42(6):577-84. PubMed ID: 2738618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease.
    Liguori C; Romigi A; Nuccetelli M; Zannino S; Sancesario G; Martorana A; Albanese M; Mercuri NB; Izzi F; Bernardini S; Nitti A; Sancesario GM; Sica F; Marciani MG; Placidi F
    JAMA Neurol; 2014 Dec; 71(12):1498-505. PubMed ID: 25322206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease.
    Mungas D; Reed BR; Jagust WJ; DeCarli C; Mack WJ; Kramer JH; Weiner MW; Schuff N; Chui HC
    Neurology; 2002 Sep; 59(6):867-73. PubMed ID: 12297568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different cognitive profiles between mild cognitive impairment due to cerebral small vessel disease and mild cognitive impairment of Alzheimer's disease origin.
    Zhou A; Jia J
    J Int Neuropsychol Soc; 2009 Nov; 15(6):898-905. PubMed ID: 19891819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
    Grundman M; Petersen RC; Ferris SH; Thomas RG; Aisen PS; Bennett DA; Foster NL; Jack CR; Galasko DR; Doody R; Kaye J; Sano M; Mohs R; Gauthier S; Kim HT; Jin S; Schultz AN; Schafer K; Mulnard R; van Dyck CH; Mintzer J; Zamrini EY; Cahn-Weiner D; Thal LJ;
    Arch Neurol; 2004 Jan; 61(1):59-66. PubMed ID: 14732621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease.
    Del-Ser T; Munoz DG; Hachinski V
    Neurology; 1996 Mar; 46(3):682-6. PubMed ID: 8618667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity and specificity of death certificate diagnoses for dementing illnesses, 1988-1990.
    Macera CA; Sun RK; Yeager KK; Brandes DA
    J Am Geriatr Soc; 1992 May; 40(5):479-81. PubMed ID: 1634701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
    Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
    Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis.
    Weamer EA; Emanuel JE; Varon D; Miyahara S; Wilkosz PA; Lopez OL; Dekosky ST; Sweet RA
    Int Psychogeriatr; 2009 Feb; 21(1):78-85. PubMed ID: 18814807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immediate causes of death of demented and non-demented elderly.
    Kammoun S; Gold G; Bouras C; Giannakopoulos P; McGee W; Herrmann F; Michel JP
    Acta Neurol Scand Suppl; 2000; 176():96-9. PubMed ID: 11261812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study.
    Jellinger KA; Attems J
    Acta Neuropathol; 2003 Jan; 105(1):14-7. PubMed ID: 12471455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome.
    Frisoni GB; Galluzzi S; Bresciani L; Zanetti O; Geroldi C
    J Neurol; 2002 Oct; 249(10):1423-32. PubMed ID: 12382161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 'natural' endpoint of dementia: death from cachexia or dehydration following palliative care?
    Koopmans RT; van der Sterren KJ; van der Steen JT
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):350-5. PubMed ID: 17022107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms.
    Marin DB; Green CR; Schmeidler J; Harvey PD; Lawlor BA; Ryan TM; Aryan M; Davis KL; Mohs RC
    J Am Geriatr Soc; 1997 Nov; 45(11):1331-8. PubMed ID: 9361658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive impairment: an independent predictor of excess mortality: a cohort study.
    Sachs GA; Carter R; Holtz LR; Smith F; Stump TE; Tu W; Callahan CM
    Ann Intern Med; 2011 Sep; 155(5):300-8. PubMed ID: 21893623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.